Exelon Patch (rivastigmine transdermal patch) 10 cm²
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Exelon Patch (rivastigmine transdermal patch) 10 cm², covering 2017-03-28 to 2017-03-28. Get the full timeline:
Most recent: Clinical Trial Update: Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease. [Phase 4]